Relmada Therapeutics Inc
(NAS:RLMD)
$
4.54
-0.41 (-8.28%)
Market Cap: 484.28 Mil
Enterprise Value: 266.55 Mil
PE Ratio: 0
PB Ratio: 2.17
GF Score: 29/100 Relmada Therapeutics Inc (RLMD) Transcripts
- 1